Hjertemagnyl 150mg / 75mg – Prophylaxis of Coronary Thrombosis, Infarction, Stroke

Hjertemagnyl: An Effective Treatment for Thrombosis Prevention

Hjertemagnyl is primarily used to prevent thrombosis in patients with ischemic heart disease, myocardial infarction, ischemic stroke, or transient ischemic attack (TIA). Additionally, it inhibits platelet aggregation, reducing the risk of clot formation. In this article, we will explore the composition of the product, discuss the recommended usage guidelines, and highlight important considerations.

Composition:

It contains acetylsalicylic acid as the active substance, with each film-coated tablet containing 150 mg. The tablet core comprises magnesium hydroxide, potato starch, magnesium stearate, maize starch, and microcrystalline cellulose. The film coating includes hypromellose, propylene glycol, and talc.

Recommended Usage: To ensure safe and effective use, follow the instructions provided by your healthcare professional or refer to the accompanying leaflet. Adults should take one tablet (75 to 150 mg) per day. If adjustments below 150 mg are necessary, use tablets of different strengths as directed by your healthcare provider. Consult your doctor with any concerns or questions.

Administration:

For convenient administration, swallow Hjertemagnyl tablets whole with water. If you have difficulty swallowing the tablet, you may divide it into smaller parts or chew it before swallowing.

Considerations for Specific Groups:

1. Children and Adolescents: Hjertemagnyl is not suitable for individuals under 16 years old or those aged 16 to 18 years.
2. Elderly Patients: Consult your doctor before using Hjertemagnyl if you are an elderly patient.
3. Patients with Renal Impairment: No dose adjustment is required for mild to moderate renal impairment, but exercise caution. Do not use Hjertemagnyl in cases of severe renal impairment.
4. Patients with Hepatic Impairment: No dose adjustment is required for mild to moderate hepatic impairment, but exercise caution. Avoid using Hjertemagnyl in cases of severe hepatic impairment.

Important Warnings:

• Adhere to the recommended daily dose and avoid exceeding it.
• Consult your doctor before using Hjertemagnyl if you are pregnant, breastfeeding, or have underlying medical conditions.
• The effectiveness of Hjertemagnyl may be influenced by the consumption of spicy foods, products containing mint, and the use of stimulating substances. Exercise caution when using such substances alongside Hjertemagnyl.
• Homeopathic medicines may cause temporary exacerbation of symptoms. If aggravation persists, discontinue the use of the product and seek guidance from your doctor or pharmacist.

Conclusion:

Hjertemagnyl is an effective preventive measure against thrombosis in various cardiovascular conditions. Understanding its composition, following the recommended usage guidelines, and being aware of specific considerations for different patient groups contribute to the safe and effective use of this medication. Consult your healthcare professional for personalized advice and guidance.